KIT and myocardial infarction: To study the potential therapeutic effects of cardiac telocytes in MI, series of young female SD rats (3 months old; n = 5 for the cardiac telocyte-injected group; n = 9 for the c-kit negative cell injection group; n = 8 for the PBS control group) were used to establish myocardial infarction as previously described [20].